We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01577550
Recruitment Status : Completed
First Posted : April 16, 2012
Last Update Posted : November 16, 2016
Boehringer Ingelheim
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2013
  Study Completion Date : May 2014